6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01790126 [Disease Site] Prostate Cancer [Description] 
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description